BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3
478 results:

  • 1. WNT5B drives osteosarcoma stemness, chemoresistance and metastasis.
    Perkins RS; Murray G; Suthon S; Davis L; Perkins NB; Fletcher L; Bozzi A; Schreiber SL; Lin J; Laxton S; Pillai RR; Wright AJ; Miranda-Carboni GA; Krum SA
    Clin Transl Med; 2024 May; 14(5):e1670. PubMed ID: 38689429
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genetic Ablation of STE20-Type Kinase MST4 Does Not Alleviate Diet-Induced MASLD Susceptibility in Mice.
    Caputo M; Andersson E; Xia Y; Hou W; Cansby E; Erikson M; Lind DE; Hallberg B; Amrutkar M; Mahlapuu M
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397122
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. RhoGDIβ inhibition via miR-200c/AUF1/sox2/miR-137 axis contributed to lncRNA MEG3 downregulation-mediated malignant transformation of human bronchial epithelial cells.
    Yang Y; Tian Z; He L; Meng H; Xie X; Yang Z; Wang X; Zhao Y; Huang C
    Mol Carcinog; 2024 May; 63(5):977-990. PubMed ID: 38376344
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. sox2 Expression Does Not Guarantee cancer Stem Cell-like Characteristics in lung Adenocarcinoma.
    Bae SH; Lee KY; Han S; Yun CW; Park C; Jang H
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334608
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. MUC1-EGFR crosstalk with IL-6 by activating NF-κB and MAPK pathways to regulate the stemness and paclitaxel-resistance of lung adenocarcinoma.
    Xu H; Du Z; Li Z; Liu X; Li X; Zhang X; Ma J
    Ann Med; 2024 Dec; 56(1):2313671. PubMed ID: 38325364
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Ultrasensitive electrochemical immunosensor system for determination of autologous sox2 antibody.
    Özçelikay-Akyıldız G; Ünal MA; Atakan Ş; Gülden S; Kızılelma B; Aydın S; Ozkan SA
    J Pharm Biomed Anal; 2024 Apr; 241():115992. PubMed ID: 38277708
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The impact of LncRNA-sox2-OT/let-7c-3p/SKP2 Axis on head and neck squamous cell carcinoma progression: Insights from bioinformatics analysis and experimental validation.
    Wang D; Zhao X; Li S; Guo H; Li S; Yu D
    Cell Signal; 2024 Mar; 115():111018. PubMed ID: 38110167
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. USP13 drives lung squamous cell carcinoma by switching lung club cell lineage plasticity.
    Kwon J; Zhang J; Mok B; Allsup S; Kim C; Toretsky J; Han C
    Mol Cancer; 2023 Dec; 22(1):204. PubMed ID: 38093367
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification of multiple organ metastasis-associated hub mRNA/miRNA signatures in non-small cell lung cancer.
    Zu L; He J; Zhou N; Tang Q; Liang M; Xu S
    Cell Death Dis; 2023 Dec; 14(12):798. PubMed ID: 38057344
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Diagnosis of Malignant Pulmonary Nodules Using a Combination of Tumor-associated Autoantibodies and Computed Tomography.
    Liu X; Shen Q; Wen Y; Jiang Z; Ma Z; Zeng P; He J; Liao Y; Huang Y; Huang J
    Am J Clin Oncol; 2024 Apr; 47(4):149-154. PubMed ID: 38054473
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Evaluation of the application value of seven tumor-associated autoantibodies in non-small cell lung cancer based on machine learning algorithms].
    Hao Y; Wu LN; Lyu YT; Liu YZ; Qin XS; Zheng R
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Nov; 57(11):1827-1838. PubMed ID: 38008573
    [No Abstract]    [Full Text] [Related]  

  • 12. [Primary synovial sarcoma of lung: a clinicopathological analysis of 12 cases].
    Zhang XW; Wei JG; Sun JP; Xu ZG; Cheng Q; Zhang L; Kong LF
    Zhonghua Bing Li Xue Za Zhi; 2023 Nov; 52(11):1120-1125. PubMed ID: 37899317
    [No Abstract]    [Full Text] [Related]  

  • 13. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
    Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham MP; Lucas P; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
    J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857525
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prolonged exposure of environmental concentration benzo[a]pyrene promoted cancer stemness through AhR/PKA/sox2 dependent pathway in small cell lung cancer.
    Ni H; Tang S; Yuan X; Xu J; Zheng F; Chen K; Liu X; Zhang H; Hu J; Xia D; Wu Y
    Sci Total Environ; 2024 Jan; 906():167824. PubMed ID: 37839474
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Epidermal growth factor receptor regulates lineage plasticity driving transformation to small cell lung cancer.
    Jing M; He X; Cai CZ; Ma QZ; Li K; Zhang BX; Yin Y; Shi MS; Wang YS
    Biochem Biophys Res Commun; 2023 Nov; 681():218-224. PubMed ID: 37783120
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Epigenetic reprogramming of a distal developmental enhancer cluster drives sox2 overexpression in breast and lung adenocarcinoma.
    Abatti LE; Lado-Fernández P; Huynh L; Collado M; Hoffman MM; Mitchell JA
    Nucleic Acids Res; 2023 Oct; 51(19):10109-10131. PubMed ID: 37738673
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Targeted Proteomic Quantitation of NRF2 Signaling and Predictive Biomarkers in HNSCC.
    Wamsley NT; Wilkerson EM; Guan L; LaPak KM; Schrank TP; Holmes BJ; Sprung RW; Gilmore PE; Gerndt SP; Jackson RS; Paniello RC; Pipkorn P; Puram SV; Rich JT; Townsend RR; Zevallos JP; Zolkind P; Le QT; Goldfarb D; Major MB
    Mol Cell Proteomics; 2023 Nov; 22(11):100647. PubMed ID: 37716475
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Exportin 1 inhibition prevents neuroendocrine transformation through sox2 down-regulation in lung and prostate cancers.
    Quintanal-Villalonga A; Durani V; Sabet A; Redin E; Kawasaki K; Shafer M; Karthaus WR; Zaidi S; Zhan YA; Manoj P; Sridhar H; Shah NS; Chow A; Bhanot UK; Linkov I; Asher M; Yu HA; Qiu J; de Stanchina E; Patel RA; Morrissey C; Haffner MC; Koche RP; Sawyers CL; Rudin CM
    Sci Transl Med; 2023 Aug; 15(707):eadf7006. PubMed ID: 37531417
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Long non-coding RNA sox2-OT enhances cancer biological traits via sponging to tumor suppressor miR-122-3p and miR-194-5p in non-small cell lung carcinoma.
    Dodangeh F; Sadeghi Z; Maleki P; Raheb J
    Sci Rep; 2023 Jul; 13(1):12371. PubMed ID: 37524903
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. LAGE3 promotes cell metastasis and stemness in non-small cell lung cancer companied with AKT/PI3K signaling pathway activation.
    Zhang H; Jian J; Chen H; Zhu X; Xie J; Xu X
    Pathol Res Pract; 2023 Aug; 248():154700. PubMed ID: 37473499
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 24.